Project Grant HT94252510752
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$1.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bar Harbor, ME 04609, USA
Similar Awards
The Defense Health Agency has awarded a $601,272 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Jackson Laboratory in Bar Harbor, Maine. The grant, with a performance period from August 1, 2025 to July 31, 2028, will fund research to reveal spatial transcriptomic and proteomic shifts in tumor-infiltrating immunocytes, charting a path to enhanced melanoma therapeutics. As a leading nonprofit biomedical research institution, the Jackson Laboratory...
This federal Project Grant award of $276,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Jackson Laboratory in Bar Harbor, Maine. The project aims to develop "whole-brain radiopathomic mapping of glioblastoma infiltration", which will transform healthcare for military service members, veterans, and the broader public by advancing the diagnosis and treatment of this deadly brain cancer. The...
This Project Grant award of $172,355 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of Connecticut Health Center to investigate spatial transcriptomic and proteomic shifts in tumor-infiltrating immunocytes, with the goal of enhancing melanoma therapeutics. The research aims to chart a path for improved treatment of melanoma by mapping changes in gene expression and protein levels within immune cells...
The federal Project Grant award of $974,355.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Sanford Burnham Prebys Medical Discovery Institute. The award supports a research project entitled "WHITE ADIPOSE TISSUE SURROUNDING LYMPH NODES MODULATES ANTIMELANOMA IMMUNITY" with a performance period from July 1, 2024 to June 30, 2027. The funding will enable the Sanford Burnham Prebys Medical Discovery...
The federal Project Grant award in the amount of $986,518.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The grant supports the "RARE MELANOMA TRANSLATIONAL CORE: COLLABORATIVE HUB TO ADVANCE THE TREATMENT OF RARE ACRAL AND MUCOSAL MELANOMAS" research project, which aims to transform healthcare for military service members, veterans, and the broader public through innovative and...
The federal Project Grant award of $3,120,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by Thomas Jefferson University's Sidney Kimmel Medical College on novel tumor-targeted immunotherapies against metastatic uveal melanoma. This 4-year award, running from September 1, 2025 to August 31, 2029, aims to transform healthcare for military service members, veterans, and the broader public through innovative...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,158,989.00 to Yale University to conduct research on optimizing adoptive cellular immunotherapy for rare melanomas. The research project commenced on September 1, 2023 and is scheduled for completion by August 31, 2026. The key objectives of this grant-funded research are to advance innovative medical solutions for rare forms of melanoma that are difficult to...
The Institute For Cancer Research has been awarded a $940,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct a mouse model study of epigenetic events in melanomagenesis. This 3-year grant, with a period of performance from July 1, 2024 to June 30, 2027, will enable the non-profit research organization to investigate the underlying epigenetic mechanisms driving the development of melanoma. As a prime grantee, The...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The Defense Health Agency awarded a $754,445 Project Grant to Jackson Laboratory, a nonprofit biomedical research organization, under the Military Medical Research and Development program (CFDA 12.420). The three-year award, effective August 15, 2023 through August 14, 2026, is funding research to target the cGAS-STING axis in order to limit inflammation and neuropathology associated with Gulf War Illness. Jackson Laboratory, located in Bar Harbor, Maine, has extensive experience conducting...